These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Presence of hyaluronan in lung alveoli in severe Covid-19: An opening for new treatment options? Hellman U; Karlsson MG; Engström-Laurent A; Cajander S; Dorofte L; Ahlm C; Laurent C; Blomberg A J Biol Chem; 2020 Nov; 295(45):15418-15422. PubMed ID: 32978255 [TBL] [Abstract][Full Text] [Related]
3. Elevated hyaluronic acid levels in severe SARS-CoV-2 infection in the post-COVID-19 era. Li Y; Cui X; Zhu N; Lin Y; Li X Front Cell Infect Microbiol; 2024; 14():1338508. PubMed ID: 38390620 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 RNA elements share human sequence identity and upregulate hyaluronan via NamiRNA-enhancer network. Li W; Yang S; Xu P; Zhang D; Tong Y; Chen L; Jia B; Li A; Lian C; Ru D; Zhang B; Liu M; Chen C; Fu W; Yuan S; Gu C; Wang L; Li W; Liang Y; Yang Z; Ren X; Wang S; Zhang X; Song Y; Xie Y; Lu H; Xu J; Wang H; Yu W EBioMedicine; 2022 Feb; 76():103861. PubMed ID: 35124429 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronan in the pathogenesis of acute and post-acute COVID-19 infection. Barnes HW; Demirdjian S; Haddock NL; Kaber G; Martinez HA; Nagy N; Karmouty-Quintana H; Bollyky PL Matrix Biol; 2023 Feb; 116():49-66. PubMed ID: 36750167 [TBL] [Abstract][Full Text] [Related]
6. IL-13 is a driver of COVID-19 severity. Donlan AN; Sutherland TE; Marie C; Preissner S; Bradley BT; Carpenter RM; Sturek JM; Ma JZ; Moreau GB; Donowitz JR; Buck GA; Serrano MG; Burgess SL; Abhyankar MM; Mura C; Bourne PE; Preissner R; Young MK; Lyons GR; Loomba JJ; Ratcliffe SJ; Poulter MD; Mathers AJ; Day AJ; Mann BJ; Allen JE; Petri WA JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34185704 [TBL] [Abstract][Full Text] [Related]
7. Lung Epithelial Cell Transcriptional Regulation as a Factor in COVID-19-associated Coagulopathies. FitzGerald ES; Chen Y; Fitzgerald KA; Jamieson AM Am J Respir Cell Mol Biol; 2021 Jun; 64(6):687-697. PubMed ID: 33740387 [TBL] [Abstract][Full Text] [Related]
8. Sex Differences in Lung Imaging and SARS-CoV-2 Antibody Responses in a COVID-19 Golden Syrian Hamster Model. Dhakal S; Ruiz-Bedoya CA; Zhou R; Creisher PS; Villano JS; Littlefield K; Ruelas Castillo J; Marinho P; Jedlicka AE; Ordonez AA; Bahr M; Majewska N; Betenbaugh MJ; Flavahan K; Mueller ARL; Looney MM; Quijada D; Mota F; Beck SE; Brockhurst J; Braxton AM; Castell N; Stover M; D'Alessio FR; Metcalf Pate KA; Karakousis PC; Mankowski JL; Pekosz A; Jain SK; Klein SL; mBio; 2021 Aug; 12(4):e0097421. PubMed ID: 34253053 [TBL] [Abstract][Full Text] [Related]
9. Hyaluronan in COVID-19: a matrix for understanding lung disease. Dodd RJ; Allen JE; Day AJ mBio; 2024 Dec; 15(12):e0260924. PubMed ID: 39555923 [TBL] [Abstract][Full Text] [Related]
10. The SARS-CoV-2 spike S1 protein induces global proteomic changes in ATII-like rat L2 cells that are attenuated by hyaluronan. Mobley JA; Molyvdas A; Kojima K; Ahmad I; Jilling T; Li JL; Garantziotis S; Matalon S Am J Physiol Lung Cell Mol Physiol; 2023 Apr; 324(4):L413-L432. PubMed ID: 36719087 [TBL] [Abstract][Full Text] [Related]
11. The role of hyaluronan synthesis and degradation in the critical respiratory illness COVID-19. Albtoush N; Petrey AC Am J Physiol Cell Physiol; 2022 Jun; 322(6):C1037-C1046. PubMed ID: 35442830 [TBL] [Abstract][Full Text] [Related]
13. Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters. Takamatsu Y; Imai M; Maeda K; Nakajima N; Higashi-Kuwata N; Iwatsuki-Horimoto K; Ito M; Kiso M; Maemura T; Takeda Y; Omata K; Suzuki T; Kawaoka Y; Mitsuya H J Virol; 2022 Feb; 96(4):e0155121. PubMed ID: 34818068 [TBL] [Abstract][Full Text] [Related]
14. Cytokines and Lipid Mediators of Inflammation in Lungs of SARS-CoV-2 Infected Mice. Dubuc I; Prunier J; Lacasse É; Gravel A; Puhm F; Allaeys I; Archambault AS; Gudimard L; Villano R; Droit A; Flamand N; Boilard É; Flamand L Front Immunol; 2022; 13():893792. PubMed ID: 35812400 [TBL] [Abstract][Full Text] [Related]
15. Lipid and Nucleocapsid N-Protein Accumulation in COVID-19 Patient Lung and Infected Cells. Grootemaat AE; van der Niet S; Scholl ER; Roos E; Schurink B; Bugiani M; Miller SE; Larsen P; Pankras J; Reits EA; van der Wel NN Microbiol Spectr; 2022 Feb; 10(1):e0127121. PubMed ID: 35171025 [TBL] [Abstract][Full Text] [Related]
16. Dynamic Changes of the Blood Chemistry in Syrian Hamsters Post-Acute COVID-19. Hsu CJ; Lin WC; Chou YC; Yang CM; Wu HL; Cheng YH; Liu PC; Chang JY; Chen HY; Sun JR Microbiol Spectr; 2022 Feb; 10(1):e0236221. PubMed ID: 35196799 [TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 infection of primary human lung epithelium for COVID-19 modeling and drug discovery. Mulay A; Konda B; Garcia G; Yao C; Beil S; Villalba JM; Koziol C; Sen C; Purkayastha A; Kolls JK; Pociask DA; Pessina P; de Aja JS; Garcia-de-Alba C; Kim CF; Gomperts B; Arumugaswami V; Stripp BR Cell Rep; 2021 May; 35(5):109055. PubMed ID: 33905739 [TBL] [Abstract][Full Text] [Related]